1Abramson D H, Beaverson L, Sangani P, et al. Screening for retinoblastoma: presenting signs as prognosticators of patient and ocular survival[J]. Pediatrics, 2003, 19(9):788-790.
2Shields C L, Shields J A. Diagnosis and managerement of retinoblastoma[J]. Cancer Control, 2004, 11:317-327.
3Rusthoven J,Bramwell V,Stephenson B.Use of granulo-cyte Colony-stimulating facor in patients receiving myelosuppressive chemotherapy for the treatment of can-cer: provincial sytemic treatment disease site group .Canc-er Prov Control,1998,(1):179
4Shelds CL, Sheds JS. Recent developments in the management of retinoblastona. J Pediatr Ophthalmol, 1999,36 (11): 8 .
5Shelds CL, Shelds JS, Potter PD. Chemoreduction in the initial management of intraocular retinoblastoma. Arch Ophthalmol, 1996, 114 (11): 1330.
6Beck MN, Bslmer A, Dressing C. First-line chemotherapy with local trentment can prevent extramal-beam irradiation and enucleation in low-stage intraocular retinoblastoma. J Clin oncol, 2000, 18 (15): 2881.
7Friedman DL, Himelstein B, Shelds CL. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma.J Clin oncol, 2000, 18 (1): 12.
8Benz MS, Scott IU, Murry TG. Complication of systemic chemotherapy as treatment of retinoblastoma. Arch Ophthalmol, 2000, 118 (1): 577.
9Sander BM, Draper GJ, Kingston JE, et al. Retinoblastoma in Great British 1969-80:incidence,treatment,and survival. Br J Ophthalmol,1988, 72 (5): 576.
10Uusitalo MS, Van Quill KR, Scott IU, et al. Evulation of chemoprophylaxis in patients with unlateral retinoblastoma with high-risk features on histopathologic examination. Arch Ophthalmol, 2001, 119 (1): 41.
5Ahramson DH, Melson MR, Dunkel I J, et al. Third (fourth and fifth)nonocular tumors in survivors of retinoblastoma [J]. Ophthalmology,2001,10(8):1868-1876.
